10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.
Revenue (Most Recent Fiscal Year) | $618.73M |
Net Income (Most Recent Fiscal Year) | $-255.10M |
PE Ratio (Current Year Earnings Estimate) | -- |
PE Ratio (Trailing 12 Months) | -- |
PEG Ratio (Long Term Growth Estimate) | -- |
Price to Sales Ratio (Trailing 12 Months) | 5.58 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 4.65 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
Pre-Tax Margin (Trailing 12 Months) | -40.21% |
Net Margin (Trailing 12 Months) | -41.17% |
Return on Equity (Trailing 12 Months) | -28.82% |
Return on Assets (Trailing 12 Months) | -22.67% |
Current Ratio (Most Recent Fiscal Quarter) | 4.69 |
Quick Ratio (Most Recent Fiscal Quarter) | 4.11 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
Inventory Turnover (Trailing 12 Months) | 2.61 |
Book Value per Share (Most Recent Fiscal Quarter) | $6.22 |
Earnings per Share (Most Recent Fiscal Quarter) | $-0.41 |
Earnings per Share (Most Recent Fiscal Year) | $-1.66 |
Diluted Earnings per Share (Trailing 12 Months) | $-2.17 |
Exchange | NASDAQ |
Sector | Healthcare |
Industry | Health Information Services |
Common Shares Outstanding | 119.17M |
Free Float | 106.48M |
Market Capitalization | $3.45B |
Average Volume (Last 20 Days) | 1.42M |
Beta (Past 60 Months) | 1.90 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 10.65% |
Percentage Held By Institutions (Latest 13F Reports) | 84.68% |
Annual Dividend (Based on Last Quarter) | $0.00 |
Dividend Yield (Based on Last Quarter) | 0.00% |